PLUR
Pluri Inc.
NASDAQ · Healthcare · Biotechnology · IL
$1.34
−2.03%Aug 27, 2026, 12:00 UTC
Pluri Inc. priced a registered direct offering and concurrent private placement of 2,228,940 common shares at $1.50 per share to a single healthcare-focused institutional investor, expecting gross proceeds of approximately $3.3 million.
Source:Jul 28, 2026, 12:00 UTC
Pluri Inc.'s subsidiary Cellav completed cosmetic regulatory registration in the UK for its regenerative aesthetics product Regenativo+.
Source: